Determinação de Di(2-etilhexil ftalato) liberado no sangue por linhas de PVC durante o procedimento de hemodiálise

O objetivo deste trabalho é demonstrar a aplicabilidade da Cromatografia Líquida de Alta Eficiência na quan-tificação do Di(2-etilhexil ftalato) (DEHP) liberado pela linha de Policloreto de vinila (PVC) no sangue cir-culante durante o procedimento de hemodiálise. Como a proposta não é a validação do método foram coleta-das amostras de sangue de cinco pacientes voluntários e de três voluntários saudáveis e os plasmas foram isolados, preparados e analisados. A concentração média de DEHP no sangue no plasma dos pacientes foi 0.19À0.12 mg/kg de massa corpórea, enquanto que no plasma dos voluntários saudáveis foi 0.003À0.002 μg/kg de massa corpórea. Os resultados mostraram que o método apresentado é uma alternativa para a de-terminação de DEPH no sangue e que poderá auxiliar na busca por outros materiais para aplicação em equi-pamentos de circulação extracorpórea. O estudo foi realizado de acordo com os padrões nacionais e interna-cionais de ética em pesquisa envolvendo seres humanos (CEP PUCPR Prot. n.5802).Palavras-chave: Diálise renal, Toxicidade crônica, DEHP

Ethanol radicals and nucleic acid alkylation studies in vitro and in vivo studies

O consumo de álcool vem sendo associado a um aumento do risco de câncer e a uma situação de estresse oxidativo. Os metabólitos responsáveis por tais processos permanecem em discussão. Neste trabalho, caracterizamos novos metabólitos radicalares do etanol e examinamos suas interações com ácidos nucléicos. Primeiramente, demonstramos que os radicais 1-hidroxietila e 2-hidroxietila produzidos durante a oxidação do etanol por sistemas Fenton alquilam DNA e RNA in vitro produzindo os adutos 8-(1-HE)Gua e 8-(2-HE)Gua, respectivamente. Esses adutos foram sintetizados e caracterizados quimicamente. Também, demonstramos que acetaldeído, o principal metabólito do etanol, é oxidado por sistemas Fenton, peroxinitrito, xantina oxidase, partículas submitocondriais e ratos a radicais acetila e metila. Esses radicais foram caracterizados e seus mecanismos de formação elucidados, pelo menos in vitro. A possibilidade do radical 1-hidroxietila alquilar ácidos nucléicos in vivo foi também examinada. Inesperadamente, o aduto 8-(1-HE)Gua foi detectado em RNA e DNA do fígado de ratos controle e seus níveis não foram significativamente alterados após administração aguda de etanol. Esses resultados sugerem que os radicais 1-hidroxietila, acetila e metila são importantes metabólitos do etanol in vivo mas atacam preferencialmente outras biomoléculas que não ácidos nucléicos.Alcohol consumption has been associated with increased cancer risk and an oxidative stress condition. Ethanol metabolites responsible for these processes remain debatable. Here, we characterized novel radical metabolites of ethanol and examined their interactions with nucleic acids. First, we demonstrated that the 1-hydroxyethyl and 2-hydroxyethyl radical produced from ethanol oxidation by Fenton systems alkylated DNA and RNA in vitro to produce 8-(1HE)Gua and 8-(2-HE)Gua, respectively. Both adducts were synthesized and structurally characterized. Next, we demonstrated that acetaldehyde, the main ethanol metabolite, is oxidized by Fenton systems, peroxynitrite, xanthine oxidase, submitochondrial particles and whole rats to acetyl and methyl radicals. These radicals were characterized and their production mechanisms in vitro elucidated. The possibility of the 1-hydroxyethyl radical alkylating nucleic acids in vivo was also examined. Unexpectedly, the adduct 8-(1-HE)Gua was detected in RNA and DNA from liver of control rats and their levels were not increased by acute ethanol treatment. Overall, the results suggest that the radicals 1-hydroxyethyl, acetyl and methyl are important ethanol metabolites in vivo but they preferentially attack biomolecules other than nucleic acids

Ethanol radicals and nucleic acid alkylation studies in vitro and in vivo studies

O consumo de álcool vem sendo associado a um aumento do risco de câncer e a uma situação de estresse oxidativo. Os metabólitos responsáveis por tais processos permanecem em discussão. Neste trabalho, caracterizamos novos metabólitos radicalares do etanol e examinamos suas interações com ácidos nucléicos. Primeiramente, demonstramos que os radicais 1-hidroxietila e 2-hidroxietila produzidos durante a oxidação do etanol por sistemas Fenton alquilam DNA e RNA in vitro produzindo os adutos 8-(1-HE)Gua e 8-(2-HE)Gua, respectivamente. Esses adutos foram sintetizados e caracterizados quimicamente. Também, demonstramos que acetaldeído, o principal metabólito do etanol, é oxidado por sistemas Fenton, peroxinitrito, xantina oxidase, partículas submitocondriais e ratos a radicais acetila e metila. Esses radicais foram caracterizados e seus mecanismos de formação elucidados, pelo menos in vitro. A possibilidade do radical 1-hidroxietila alquilar ácidos nucléicos in vivo foi também examinada. Inesperadamente, o aduto 8-(1-HE)Gua foi detectado em RNA e DNA do fígado de ratos controle e seus níveis não foram significativamente alterados após administração aguda de etanol. Esses resultados sugerem que os radicais 1-hidroxietila, acetila e metila são importantes metabólitos do etanol in vivo mas atacam preferencialmente outras biomoléculas que não ácidos nucléicos.Alcohol consumption has been associated with increased cancer risk and an oxidative stress condition. Ethanol metabolites responsible for these processes remain debatable. Here, we characterized novel radical metabolites of ethanol and examined their interactions with nucleic acids. First, we demonstrated that the 1-hydroxyethyl and 2-hydroxyethyl radical produced from ethanol oxidation by Fenton systems alkylated DNA and RNA in vitro to produce 8-(1HE)Gua and 8-(2-HE)Gua, respectively. Both adducts were synthesized and structurally characterized. Next, we demonstrated that acetaldehyde, the main ethanol metabolite, is oxidized by Fenton systems, peroxynitrite, xanthine oxidase, submitochondrial particles and whole rats to acetyl and methyl radicals. These radicals were characterized and their production mechanisms in vitro elucidated. The possibility of the 1-hydroxyethyl radical alkylating nucleic acids in vivo was also examined. Unexpectedly, the adduct 8-(1-HE)Gua was detected in RNA and DNA from liver of control rats and their levels were not increased by acute ethanol treatment. Overall, the results suggest that the radicals 1-hydroxyethyl, acetyl and methyl are important ethanol metabolites in vivo but they preferentially attack biomolecules other than nucleic acids

Bowel Habits and the Association With Uremic Toxins in Non–Dialysis-Dependent Chronic Kidney Disease Patients

Objective: The aim of this study is to evaluate the association between bowel habits and microbial-derived uremic toxins p-cresyl sulfate (PCS) and indoxyl sulfate (IS) in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD). Design and Methods: This is a cross-sectional analysis including 43 nondiabetic NDD-CKD patients (58% men; 59.0 ± 13.5 years; estimated glomerular filtration rate, 21.3 ± 7.9 mL/min/1.73 m). Bowel habit was assessed by the Bristol Stool Scale (BS

Is there a relationship between tryptophan dietary intake and plasma levels of indoxyl sulfate in chronic kidney disease patients on hemodialysis?

Abstract Introduction: Gut microbiota is involved in generation of uremic toxins in chronic kidney disease (CKD) patients on hemodialysis (HD), like indoxyl sulfate (IS) that is originated from tryptophan amino acid fermentation. Objective: To evaluate the tryptophan intake by chronic renal failure patients on HD and its possible relationship with IS plasma levels. Methods: Participated of the study 46 patients with CKD on HD regular program (56.5% men; 52.7 ± 10.3 years; 63 (32.2-118.2) months on HD; BMI 25.6 ± 4.9 kg/m2). The tryptophan intake was evaluated by a 24-hours dietary recall (R-24h) performed on 3 different days. Routine biochemical tests and anthropometric measurements were evaluated. IS plasma levels were determined by High Performance Liquid Chromatography (HPLC) with fluorescent detection and the interleukin-6 (IL-6) plasma levels by immunoenzymatic method (ELISA, Enzyme Linked Immunosorbent Assay). Results: The average of tryptophan intake was according to recommendation, but IS plasma levels (35.0 ± 11.9 mg/L) were elevated, however according to the EUTox values for uremic individuals. There was no correlation between the tryptophan intake and IS plasma levels. However, there was positive correlation between protein intake and tryptophan and variables used to evaluate lean body mass, and moreover, IS levels were positively associated with IL-6 (r = 0.6: p = 0.01). Conclusion: The present study suggests that tryptophan dietary intake may not be a determinant factor to IS levels. However, it suggests that gut microbiota may play an important role in systemic inflammation in patients with CKD

Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: A randomized controlled trial

BACKGROUND: Microbial-derived uremic toxins, p-cresyl sulfate (PCS), indoxyl sulfate (IS) and indole 3-acetic acid (IAA), have been associated with the burden of chronic kidney disease (CKD). Prebiotics have emerged as an alternative to modulate the gut environment and to attenuate toxin production. This trial aims to investigate the effect of a prebiotic fructooligosaccharide (FOS) on uremic toxins of non-dialysis-dependent CKD (NDD-CKD) patients. METHODS: A double-blind, placebo-controlled, randomized trial was conducted for 3 months. In all, 50 nondiabetic NDD-CKD patients [estimated glomerular filtration rate (eGFR)

Reactivity of dinuclear copper(II) complexes towards melanoma cells: Correlation with its stability, tyrosinase mimicking and nuclease activity

International audienceIn this work, the influence of two new dinuclear copper(II) complexes in the viability of melanoma cells (B16F10 and TM1MNG3) was investigated, with the aim of verifying possible correlations between their cytotoxicity and their structure. One of the complexes had a polydentate dinucleating amine–imine ligand (complex 2), and the other a tridentate imine and a diamine-bridging ligand (complex 4). The analogous mononuclear copper(II) species (complexes 1 and 3, respectively) were also prepared for comparative studies. Crystal structure determination of complex 2 indicated a square-based pyramidal geometry around each copper, coordinated to three N atoms from the ligand and the remaining sites being occupied by either solvent molecules or counter-ions. Complex 4 has a tetragonal geometry. Interactions of these complexes with human albumin protein (HSA) allowed an estimation of their relative stabilities. Complementary studies of their reactivity towards DNA indicated that all of them are able of causing significant oxidative damage, with single and double strand cleavages, in the presence of hydrogen peroxide. However, nuclease activity of the dinuclear species was very similar and much higher than that of the corresponding mononuclear compounds. Although complex 2, with a more flexible structure, exhibits a much higher tyrosinase activity than complex 4, having a more rigid environment around the metal ion, both complexes showed comparable cytotoxicity towards melanoma cells. Corresponding mononuclear complexes showed to be remarkably less reactive as tyrosinase mimics as well as cytotoxic agents. Moreover, the dinuclear complexes showed higher cytotoxicity towards more melanogenic cells. The obtained results indicated that the structure of these species is decisive for its activity towards the malignant tumor cells tested

Indoxyl Sulfate, a Uremic Toxin, Stimulates Reactive Oxygen Species Production and Erythrocyte Cell Death Supposedly by an Organic Anion Transporter 2 (OAT2) and NADPH Oxidase Activity-Dependent Pathways

It is hypothesized that the uremic toxin indoxyl sulfate (IS) plays a role in the pathogenesis of renal anemia. To further explore that hypothesis, we examined the effects of IS on reactive oxygen species (ROS) production, levels of reduced glutathione (GSH), and erythrocyte death (eryptosis) in red blood cells (RBC) from healthy controls (CON-RBC) and hemodialyzed patients (HD-RBC), respectively. RBC were incubated either in either TRIS-Glc-BSA buffer or IS at concentrations of 0.01, 0.09, and 0.17 mM, respectively. We measured ROS generation (expressed as % of DCFH-DA positive RBC), eryptosis (expressed as % of annexin-V positive RBC), and GSH levels after 6, 12, and 24 h. When incubated in buffer, ROS production was approximately seven-fold higher at all time points HD-RBC when compared to CON-RBC. Incubation with IS increased ROS production in CON-RBS dose-dependently up to 10-fold. Eryptosis in buffer-incubated HD-RBC was up to seven-fold higher as compared to COB-RBC. Incubation of CON-RBC with IS increased the eryptosis rate dose-dependently up to 6-fold. Pretreatment of CON-RBC with the organic anion transporter 2 (OAT2) specific inhibitor ketoprofen or with NADPH oxidase inhibitor diphenyleneiodonium-Cl blunted the IS effect on both ROS production and eryptosis induction. While GSH levels in HD-RBC were reduced when compared to CON-RBC, they were not affected by IS incubation. In summary, IS increases ROS generation and eryptosis in CON-RBC by an activity dependent of the IS influx through OAT2, and NADPH oxidase activity-dependent, and a GSH-independent mechanism. These findings lend support to a putative role of IS in the pathogenesis of renal anemia

Renocardiac Effects of p-Cresyl Sulfate Administration in Acute Kidney Injury Induced by Unilateral Ischemia and Reperfusion Injury <i>In Vivo</i>

The precise mechanisms underlying the cardiovascular complications due to acute kidney injury (AKI) and the retention of uremic toxins like p-cresyl sulfate (PCS) remain incompletely understood. The objective of this study was to evaluate the renocardiac effects of PCS administration in animals subjected to AKI induced by ischemia and reperfusion (IR) injury. C57BL6 mice were subjected to distinct protocols: (i) administration with PCS (20, 40, or 60 mg/L/day) for 15 days and (ii) AKI due to unilateral IR injury associated with PCS administration for 15 days. The 20 mg/L dose of PCS led to a decrease in renal mass, an increase in the gene expression of Cystatin C and kidney injury molecule 1 (KIM-1), and a decrease in the α-actin in the heart. During AKI, PCS increased the renal injury biomarkers compared to control; however, it did not exacerbate these markers. Furthermore, PCS did not enhance the cardiac hypertrophy observed after 15 days of IR. An increase, but not potentialized, in the cardiac levels of interleukin (IL)-1β and IL-6 in the IR group treated with PCS, as well as in the injured kidney, was also noticed. In short, PCS administration did not intensify kidney injury, inflammation, and cardiac outcomes after AKI

Older Patients on Hemodiafiltration: Behavior of Uremic Toxins, Inflammation, Endothelium, and Bone Mineral Disorder

Chronic kidney disease (CKD) affects 10% of the world&rsquo;s population. Uremic toxins, such as indoxyl sulfate (IS), p-Cresylsulfate (PCS) and indole acetic acid (IAA), are not sufficiently removed by conventional hemodialysis (HD) and have been associated with inflammation, poor quality of life, bone mineral disease (BMD) and endothelial injury. Online hemodiafiltration (OL-HDF) may promote greater clearance of uremic toxins than HD. However, there are few studies evaluating the effect of OL-HDF on serum levels of IS, PCS, IAA, and biomarkers associated with inflammatory, endothelial, and bone and mineral disorder in the elderly population. We evaluated the effect of 6 months of OL-HDF on the serum concentration of uremic toxins, biomarkers of inflammation, endothelial and bone mineral disorder in older patients on OL-HDF. IS, PCS, and IAA were measured by high-performance liquid chromatography. We included 31 patients (77.4 &plusmn; 7.1 years, 64.5% male, 35.5% diabetic, on maintenance dialysis for 45 &plusmn; 20 days). From baseline to 6 months there was a decrease in serum concentration of IS but not PCS and IAA. We found no change in serum concentration of inflammatory, endothelial, or mineral and bone biomarkers. In summary, OL-HDF was capable to reduce IS in older patients. Whether this reduction may have an impact on clinical outcomes deserves further evaluation